Physician Focus on Parkinson's
Issue 18 (Summer 2011) - Quarterly CME Newsletter on Parkinson's Disease
To receive CME credit for this activity, please complete the post-test and evaluation below. You must score 70% or better on the post-test in order to receive your CME certificate. Once submitted, a certificate will be issued within two weeks to the email address provided.
Click here to view Issue 18 online. To view the AAN Quality-of-Care Measures full report, please click here.
Target Audience
Neurologists, NPs and PAs specializing in neurology, and other healthcare professionals who treat patients with Parkinson's disease.
Statement of Need
Parkinson’s disease (PD) has traditionally been classified as a movement disorder as its cardinal symptoms include tremor, rigidity, slowed movement and postural instability. However the importance of psychiatric and other non-motor symptoms (NMS) in the detection of disease and their impact on quality of life has forced clinicians to envision PD as a complex disorder that requires careful and thorough evaluation throughout their patients’ lifetimes. It is necessary to understand that NMS often present early in disease, and it is the worsening of these symptoms that may spur individuals to seek medical attention. With disease progression, these symptoms invariably become more debilitating and are a clinical challenge to control over the long run. In addition to dopaminergic therapy, patients may require additional pharmacologic agents to control symptoms, adding to their burden of cost and complexity as they seek to sustain quality of life. Learning Objectives
At the conclusion of this activity, participants should be able to:
Discuss how the course of disease and range of symptoms in young-onset PD patients differs from older-onset patients Name potential challenges in the management of young-onset PD as well as treatment strategies Explain how to use the AAN guidelines in caring for your patients with PD Discuss the results of recent research in PD
Disclosures
Lauren Seeberger, MD (Case Study Contributor)
Gary VanderArk, MD (Independent Reviewer)
Richard Robinson (Medical Writer)
Accreditation Statement
intellyst® Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
intellyst® Medical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
If you have any questions, please contact intellyst® Medical Education at 720-748-8800.
|
|
|
|
|
| Compared to Parkinsons disease in patients with older age of onset, PD in patients with young-onset is more likely to be: |
|
| A patient with young-onset PD inquires about the possibility of genetic testing for the parkin gene. Which of the following statements is NOT consistent with the current state of knowledge and best practice in the area of genetic testing for PD? |
|
| Compared to patients with older-onset, patients with young-onset PD tend to have: |
|
A new YOPD patient is in your office with mild rigidity, mild bradykinesia, and an almost imperceptible tremor in the right hand. What is the best initial treatment for this patient for these symptoms?
|
| In addition to discussion of treatment for motor symptoms, what other issue(s) may be appropriate for the physician to raise with the patient early on in the disease? |
|
| According to the AAN Quality-of-Care Measures, inquiries about which symptoms should be made at every clinic visit? |
|
| According to the AAN Quality-of-Care Measures, Parkinsons disease medical and surgical treatment options should be reviewed only once per year. |
|
| According to a study of group visits in PD, which of the following statements best characterizes the effect of group visits on quality of life? |
|
Which aspects of group visits are most appealing to you, and may be of benefit to your PD patients?
|
| The most common gene mutations found in YOPD patients are in the genes for: |
|
|
|
|
|
Please evaluate the activity objectives by selecting how well each has been met, with 5 indicating excellent and 1 indicating poor.
|
| Discuss how the course of disease and range of symptoms in young-onset PD patients differs from older-onset patients. | |
| Name potential challenges in the management of young-onset PD as well as treatment strategies. | |
| Explain how to use the AAN guidelines in caring for your patients with PD. | |
| Discuss the results of recent research in PD. | |
Please evaluate the effectiveness of the case study by Dr. Lauren Seeberger, in both areas listed below, with 5 indicating excellent and 1 indicating poor.
|
| Usefulness of information presented. | |
| Objectivity/fair balance of content. | |
| Do you intend to make changes or apply this information to your practice as a result of this activity? |
|
Please explain your response to the above question:
|
| Was there any commercial bias in relation to this activity? | |
If yes, please describe.
|
NEW!!! We will be posting an Ask the Expert" section of subsequent issues of Physician Focus on Parkinsons. Please take this unique opportunity to ask a question of our editorial board (Lawrence Elmer, MD; Robert Hauser, MD; Lauren Seeberger, MD; Andrew Siderowf, MD). Your question and the expert panel response may be published in the next issue.
|
| First Name | |
| Last Name | |
| Degree/Credentials | |
| Phone | |
| Fax | |
| Email | |
| How did you hear about this Physician Focus on Parkinsons activity? | |
By typing your name below, this will act as your signature.
|
| Signature | |
| Date | 
|
|
|
|
|
|